Introduction
The hormonal form of vitamin D, 1,25(OH)2D, is synthesized mostly in proximal renal tubular cells. Experimental and clinical studies suggest that the growth hormone may be involved in growth-related fluctuations of plasma 1,25(OH)2D and in the increase of 1,25(OH)2D induced by in vivo phosphate deprivation, an action possibly mediated by insulin-like growth factor 1 (IGF 1). We tested the effects of phosphate depletion and IGF 1 addition on 1,25(OH)2D3 production in cultured kidney cells: opossum kidney (OK) cells, LLC-PK 1, and rabbit's proximal tubular cells.
Confluent cell monolayers were preincubated in various phosphate concentrations, in the presence and absence of IGF 1. Then, 5 
nM of [3H]25(OH)D3 or 2 ,uM of 25(0OH))D3
were added to the medium and the cells were incubated for a further 120 min. The amount of biosynthesized 1,25(OH)2D3 in lipid extracts was determined after two different straight phase high performance liquid chromatographies. The experiment showed the following: (a) LLC-PK 1 and rabbit's cells expressed a detectable ability to synthesize 1,25(OH)2D3, while OK cells did not. (b) Partial or total phosphate deprivation increased the amount of 1,25(OH)2D3 produced, respectively in LLC-PK 1 and in rabbit's cells. (c) IGF 1 (25 ng/ml) increased 1,25(OH)2D3 production in rabbit's cells, particularly in phosphate-free medium (1.6-fold), and in LLC-PK 1 cells, in partial phosphate depletion (2.75-fold in 1 mM phosphate, P = 0.015, n = 5, and 3.2-fold in 0.5 mM phosphate, P = 0.043, n = 4). Our findings demonstrate a local action of phosphate depletion and of IGF 1 (6) (7) (8) (9) (10) (11) . Phosphate is a particularly interesting regulator of laOHase: in animals and in humans (6, 7, 9, 10, 12, 13) , dietary phosphate restriction or low phosphate serum concentrations lead to an increase of plasma 1,25-(OH)2D concentration, but in vitro no direct effect of phosphate depletion on 1,25-(OH)2D3 production has so far been evidenced (14, 15) . Moreover, in vivo, the adaptation of 1,25-(OH)2D3 production to phosphate depletion needs integrity of the hypothalamo-hypophysis axis (16) (17) (18) (19) .
None of the above mentioned regulating factors explains the evolution of 1,25-(OH)2D synthesis during growth. The plasma concentration of 1,25-(OH)2D is higher in children than in adults. But PTH is not elevated, calcium concentrations are not decreased, and phosphate concentrations are increased, and not decreased during childhood. Experimental and clinical studies suggest that the growth hormone (GH) may be involved in these growth-related fluctuations of plasma 1,25-(OH)2D, and in the plasma 1,25-(OH)2D increase induced by in vivo phosphate deprivation (16) (17) (18) (19) . This GH action may be mediated by the insulin-like growth factor 1 (IGF 1) (20, 21) . However, the only influence of IGF 1 on laOHase activity evidenced in vitro was obtained at a pharmacological dose (22) .
To jig/ml streptomycin as previously described (24 (28) . The F4 layer, made of proximal tubules, was removed, suspended in HBS-Hepes, washed and centrifugated three times in this solution. The final pellet was suspended in the culture medium and tubules were seeded in 24-well plastic trays coated with NH3-reconstituted rat's tail collagen (2.5 X 104 fragments/well) (29) . The serum-free culture medium (30) consisted in a 1:1 (vol/vol) Ham's F-12 and DME mixture supplemented with 5 jig/ml insulin, 35 jig/ml transferrin, 10 ng/ml epithelial growth factor (EGF), 2.2 JIM retinoic acid, 20 jiM ethanolamine, and 50 nM dexamethasone. Cells were first seeded with a medium containing 1% of fetal calf serum (FCS), and cultured after the third day in a serum-free medium.
Metabolism of 25-(OH)D3 by cells in vitro. On the day before the experiment, the culture medium was changed and the cells (-50,000 cells/well) were preincubated for 16 h in 0.5 ml of a hormone and phosphate free DMEM with or without 0.5, 1, or 2 mM KH2PO4 and with or without 25 ng/ml IGF 1 
Results
Metabolism of 25-(OH)D3 by renal cells in vitro. The three types of mammalian kidney cells studied were able to convert 25-(OH)D3 into more polar metabolites. With LLC-PK 1 and rabbit's cells one of these metabolites eluting as a single peak coeluted with synthetic 1,25-(OH)2D3 on straight phase HPLC using a 92:8 n-hexane:isopropanol solvent (Fig. 1 A) and using a 95:5 methylene chloride:isopropanol solvent (Fig. 1 B) (Fig. 2) . In contrast, with OK cells, the metabolite coeluting with synthetic 1,25-(OH)2D3 in the first HPLC system (Fig. 1 C) did not coelute with the synthetic hormone in the second HPLC system (Fig. 1 D) .
Effect ofphosphate deprivation on 1,25-(OH)2D3 synthesis. In vitro phosphate deprivation of cultured rabbit's kidney cells for 16 h increased their ability to produce 1,25(OH)2D3 (Fig.  3) . The amount of 1,25 (OH)2D3 produced after 120 min incubation was 3. (Fig. 4) .
Effect ofIGF I adjunction and adaptation to different extracellular concentrations of phosphate. Incubation of rabbit's cells with 25 ng/ml human IGF 1, for 16 h, led to a limited and inconstant (3 out 5 experiments) increase in 1,25 (OH)2D3 production when cells had been cultured in a serum and hormone free medium containing 2 mM phosphate (Fig. 3 ). Yet, it had a marked stimulatory effect in cells incubated in a phosphate free medium. This effect was observed as early as 30 min after the addition of 25(OH)D3 to the medium (Fig. 3) when cells had been cultured in a serum and hormone free medium containing 2 mM phosphate, but to a marked increase in a partially phosphate depleted medium: 2.75-fold in 1 mM phosphate (P = 0.015, n = 5) and 3.2-fold in 0.5 mM phosphate (P = 0.043, n = 4), (Fig. 4) .
Discussion
We have shown that two types of mammalian kidney cells in culture (LLC-PK 1 and rabbit's tubular cells) are able to synthesize 1,25-(OH)2D3, and that this synthesis is modulated by local conditions, particularly extra-cellular phosphate concentrations and presence of IGF 1 in the medium. Up to now several types of kidney cells have been studied in vitro for their ability to produce 1,25-(OH)2D3: kidney cell homogenates, chick kidney cells in primary culture (33) (34) (35) (36) (37) (38) , and mammalian kidney cells (15, 39) . With these cells, a direct effect of PTH, 1,25-(OH)2D3, and calcitonin has been evidenced on 1,25-(OH)2D3 production, but no direct effect of physiological doses of IGF 1, or phosphate depletion had yet been demonstrated. The rationale for using the three other cell types studied in the present work is the following: (a) OK cells, obtained from an opossum kidney, were considered as tubular proximal cells because of their Pi uptake and are especially responsive to PTH, which decreases their Pi uptake and stimulates AMPc synthesis (40) ; (b) LLC-PK 1 cells, derived from a pig kidney, are known to express 1,25-(OH)2D3 receptors (41) , and a 25-(OH)D3-24-OHase responding to 1,25-(OH)2D3, they also have a Na dependent-Pi uptake, but are non sensitive to PTH (40) ; (c) Rabbit's cells in primary culture are tubular proximal cells (42, 43) : they are epithelial, oriented with a brush border, they have Na dependent uptake of phosphate, glucose, and aminoacids and they express an AMPc response to PTH but not to calcitonin.
In our study, OK cells did not express an ability to synthesize 1,25 (OH)2D3. This lack of expression may result from the conditions used in this study, or may be an argument in favor of the pars recta origin of the OK cells, as the 25-(OH)D3-laOHase has been mainly localized in the proximal convoluted tubules in chick and rat kidneys (8) . In contrast, LLC-PK 1 cells and rabbit's cells in primary culture expressed a clear 25-(OH)D3-laOHase activity, and thus proved to be new useful models for studying the laOHase enzymatic system. Indeed, these cells proved to be able to convert 25-(OH)D3 into a metabolite which shared with 1,25-(OH)2D3 identical chromatographic properties on two HPLC systems, similar UV absorbance at 254 nm, identical UV spectrum, and identical ability to compete with [3H] 1,25-(OH)2D3 for binding to the chick intestinal cytosol. The only vitamin D metabolite known to meet these criteria is 1,25-(OH)2D3 (32, 44) . These results also show that the ability to synthesize 1,25-(OH)2D3 and the sensitivity to PTH (cAMP dependent) do not necessarily coexist in the same cultured renal cell line. LLC-PK 1 cells were able to produce 1, 25 (OH)2D3 in our experimental conditions but are known not to be responsive to PTH, while OK cells were unable to synthesize 1,25 (OH)2D3 but are responsive to PTH (40) .
Using these mammalian cell models, we were able to show a local effect of phosphate and IGF 1. Phosphate plays a physiological role in the regulation of serum concentration of 1,25 (OH )2D3: oral intake and serum concentration of phosphorus alter serum concentration of 1,25 (OH)2D3 and its production rate (12, 13) , via a possibly GH-or IGF 1-dependent mechanism (16) (17) (18) (19) (20) (21) 45) . The results of our study provide the first evidence of a local action of phosphate concentration on 1,25(OH)2D3 production, not requiring exogenous IGF I: total phosphate depletion in rabbit's kidney cells and partial phosphate depletion in LLC-PK 1 had a clear stimulating effect on 1,25(OH)2D3 production. Trechsel et al. (14) in 1979 did not evidence this effect of phosphate depletion while studying cultured chick kidney cells. Two main differences in the experimental protocols may explain these discrepancies: differences in the species origin of the cells, or the use by Trechsel et al. (14) of a medium enriched with 10% FCS which may have masked the phosphate effect, while we used a serum and hormone-free medium. Fukase et al. (15) in 1982 found an inhibitory effect of high phosphate concentrations on the ability of the mouse kidney cells to produce 1,25 (OH)2D3, but did not detect any effect of phosphate depletion (15) . They concluded that the effect of phosphate deprivation is only indirect. But they used an insulin (5 Mg/ml) enriched medium to study laOHase and an interaction between this hormone and phosphate can not be excluded.
While partial phosphate depletion (1 mM) of LLC-PK 1 cells stimulated their ability to produce 1,25(OH)2D3, total phosphate depletion led to an almost complete loss of this ability. Complete phosphate depletion can deeply affect cell metabolism and the phosphorylation-dephosphorylation pathway regulating 25-(OH)D3-laOHase activity. Previous studies reported that LLC-PK 1 cells cultured in a phosphate free medium exhibit an increase of Na dependent phosphate uptake, an unaltered ATPase but a sharp decrease of intracellular phosphate and ATP (46) . IGF 1 is thought to be the messenger of phosphate depletion. In vivo studies have shown its action on phosphate mediated control of 1,25(OH)2D3 production (20, 21, 45) . But up to now, the only reported in vitro stimulating effect of IGF 1 on 1,25(OH)2D3 production was obtained with a pharmacological concentration of Somatomedin C by Spencer et al. (22) . Our results clearly show that low concentrations of exogenous IGF 1 can stimulate 1,25(OH)2D3 synthesis. This effect has not been evidenced before, probably because of the media that were used: they contained serum (and therefore IGF and IGF BPs), or insulin (which can saturate IGF 1 receptors). In keeping with what has been observed after its in vivo administration (47) , IGF 1 added directly in vitro had only a limited effect on 1,25(OH)2D3 synthesis when phosphate was at a normal level, but had a marked effect when phosphate concentration in the medium was low. Thus, IGF 1 appears to be an important regulator of the adaptation of 1,25(OH)2D3 synthesis to phosphate deprivation, although such adaptation does not require the presence of exogenous IGF 1.
Phosphate concentration and IGF 1 may act at different levels on the laOHase system. Phosphate depletion may directly enhance dephosphorylation of the ferredoxin, thus activating the laOHase (48, 49) . IGF 1 may potentiate the phos-phate depletion effect through direct action on phosphate captation (50) (51) (52) . It may also stimulate the synthesis of the cytochrome P450 component of the enzyme complex. It may finally affect dephosphorylation of the ferredoxin through a PKC mediated pathway (53) .
Whatever the mechanism involved, this first demonstration of a local effect of IGF 1 on 1,25 (OH)2D3 synthesis suggests that IGF 1 can have a double function during growth: not only of accelerating growth, but also of increasing bone mineralization through regulation of 1,25 (OH)2D3 production.
